1. High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A protocol for a systematic review of controlled trials
- Author
-
Anna Misyail Abdul Rashid, Mooi Ching Siew, Nabil Izzaatie Mohamad Safiai, Hamidon Basri, Mohd Hazmi Mohamed, Nur Afiqah Mohamad, Janudin Baharin, Intan Nureslyna Samsudin, Wei Chao Loh, Patricia Pozo-Rosich, Abdul Hanif Khan Yusof Khan, Wan Aliaa Wan Sulaiman, Liyana Najwa Inche Mat, Aaron Fernandez, Vasudevan Ramachandran, Fan Kee Hoo, Kai Wei Lee, Institut Català de la Salut, [Mohamad Safiai NI, Mohamad NA, Basri H, Inche Mat LN, Hoo FK, Abdul Rashid AM] Department of Neurology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia. [Rosich P] Unitat de Cefalea i Dolor Craniofacial, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Cefalees i Dolors Neurològics, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Otros calificadores::Otros calificadores::/prevención & control [Otros calificadores] ,Physiology ,medicine.medical_treatment ,law.invention ,Study Protocol ,Database and Informatics Methods ,0302 clinical medicine ,Randomized controlled trial ,law ,Medicine and Health Sciences ,030212 general & internal medicine ,Database Searching ,Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Headache Disorders::Headache Disorders, Primary::Migraine Disorders [DISEASES] ,Randomized Controlled Trials as Topic ,Brain Mapping ,Multidisciplinary ,Headaches ,terapéutica::magnetoterapia::estimulación magnética transcraneal [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] ,Brain ,Magnetoteràpia ,Research Assessment ,Transcranial Magnetic Stimulation ,Electrophysiology ,Bioassays and Physiological Analysis ,medicine.anatomical_structure ,Systematic review ,Brain Electrophysiology ,Tolerability ,Medicine ,Anatomy ,Therapeutics::Magnetic Field Therapy::Transcranial Magnetic Stimulation [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] ,psychological phenomena and processes ,medicine.medical_specialty ,Drug Research and Development ,Systematic Reviews ,enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos con cefaleas::cefaleas primarias::trastornos migrañosos [ENFERMEDADES] ,Migraine Disorders ,Science ,Prefrontal Cortex ,Neurophysiology ,Surgical and Invasive Medical Procedures ,Migranya - Tractament ,Research and Analysis Methods ,behavioral disciplines and activities ,03 medical and health sciences ,Other subheadings::Other subheadings::/prevention & control [Other subheadings] ,Signs and Symptoms ,Physical medicine and rehabilitation ,mental disorders ,medicine ,Humans ,Migranya - Prevenció ,Clinical Trials ,Transcranial Stimulation ,Migraine ,Pharmacology ,Functional Electrical Stimulation ,business.industry ,Electrophysiological Techniques ,Biology and Life Sciences ,medicine.disease ,Randomized Controlled Trials ,Dorsolateral prefrontal cortex ,Clinical trial ,Transcranial magnetic stimulation ,nervous system ,Brain stimulation ,Clinical Medicine ,business ,030217 neurology & neurosurgery ,Neuroscience - Abstract
Migranya; Estimulació magnètica transcranial; Escorça prefrontal Migraña; Estimulación magnética transcraneal; Corteza prefrontal Migraine; Transcranial magnetic stimulation; Prefrontal cortex Background Migraine may lead to a negative impact on the patients’ quality of life with a subsequent substantial burden to society. Therapy options for treatment and prevention of migraine have progressed over the years and repetitive transcranial magnetic stimulation (rTMS) is one of the promising non-pharmacological options. It induces and alters electric current in the brain via repetitive non-invasive brain stimulation in high frequency. In migraine patients, two common stimulation sites are the M1 cortex and dorsolateral prefrontal cortex (DLPFC). The mechanism on how rTMS exerts therapeutic effects on migraine is not fully established, but the main postulation is that the neuromodulation via high-frequency rTMS (hf-rTMS) might inhibit pain perception. However, evidence from studies has been conflicting, thus the usefulness of hf-rTMS as migraine preventive treatment is still uncertain at this moment. Methods This is a systematic review protocol describing essential reporting items based on the PRISMA for systematic review protocols (PRISMA-P) (Registration number: CRD42020220636). We aim to review the effectiveness, tolerability, and safety of hf-rTMS at DLPFC in randomised controlled trials (RCTs) as migraine prophylactic treatment. We will search Scopus, Cumulative Index to Nursing and Allied Health Literature Plus, PubMed, Cochrane Central Register of Controlled Trials and Biomed Central for relevant articles from randomised controlled clinical trials that used hf-rTMS applied at DLPFC for the treatment of migraine. The risk of bias will be assessed using the version 2 “Risk of bias” tool from Cochrane Handbook for Systematic Reviews of Interventions Version 6.1. We will investigate the evidence on efficacy, tolerability and safety and we will compare the outcomes between the hf-rTMS intervention and sham groups. Discussion This systematic review will further determine the efficacy, safety, and tolerability of hf-rTMS applied at DLPFC for migraine prophylaxis. It will provide additional data for health practitioners and policymakers about the usefulness of hf-rTMS for migraine preventive treatment. This work is funded by Research Management Centre of Universiti Putra Malaysia under research grant number GPB/2017/9585500.
- Published
- 2021